Heron Therapeutics COO exercises 31,250 RSUs

Heron Therapeutics, Inc. reported insider equity activity by Chief Operating Officer Mark Earl Hensley on August 6, 2026.

Rhea-AI Filing Summary

Heron Therapeutics, Inc. reported insider equity activity by Chief Operating Officer Mark Earl Hensley on August 6, 2026. He exercised 31,250 Restricted Stock Units, receiving an equivalent number of common shares. In a related transaction, 8,888 common shares were delivered or withheld for payment of exercise price or tax liability at $0.5000 per share. Following the transaction, he continued to hold 343,750 Restricted Stock Units representing additional contingent rights to common shares.

Insider Trade Summary

31,250 shares exercised/converted

Exercise 3 txns

Insider Hensley Mark Earl

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units F2	31,250	$0.00	$0.00
Exercise	Common Stock F1	31,250	--	--
Exercise Price or Tax Liability	Common Stock	8,888	$0.50	$4K

Holdings After Transaction: Restricted Stock Units — 343,750 contracts (Direct); Common Stock — 170,901 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents a contingent right to receive one share of common stock.
2. F2. The restricted stock units vest with 25% upon the first anniversary of date of grant (May 6, 2025) and then in twelve (12) equal quarterly installments thereafter.

Key Figures

RSUs exercised: 31,250 units Shares delivered/withheld: 8,888 shares Per-share value for F transaction: $0.5000 per share +1 more

4 metrics

RSUs exercised 31,250 units Restricted Stock Units converted into common stock on August 6, 2026

Shares delivered/withheld 8,888 shares Common shares used for payment of exercise price or tax liability

Per-share value for F transaction $0.5000 per share Value applied to 8,888 shares in code F transaction

RSUs held after transaction 343,750 units Restricted Stock Units reported as beneficially owned following RSU exercise

Key Terms

Restricted Stock Units, contingent right, vest

3 terms

Restricted Stock Units financial

"Each restricted stock unit represents a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"represents a contingent right to receive one share of common stock"

vest financial

"The restricted stock units vest with 25% upon the first anniversary"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HRTX executive Mark Earl Hensley report?

Mark Earl Hensley, COO of Heron Therapeutics (HRTX), reported exercising 31,250 Restricted Stock Units on August 6, 2026, receiving the same number of common shares and processing a related share delivery/withholding for payment of exercise price or tax liability.

How many Heron Therapeutics (HRTX) RSUs did the COO exercise?

The COO exercised 31,250 Restricted Stock Units, converting them into 31,250 shares of common stock. These RSUs each represented a contingent right to receive one share of common stock upon vesting and settlement.

How many HRTX shares were withheld or delivered for taxes or exercise price?

A total of 8,888 common shares of Heron Therapeutics were delivered or withheld to pay the exercise price or tax liability at a value of $0.5000 per share, according to the Form 4 transaction coded as “F.”

What are Mark Earl Hensley’s remaining Restricted Stock Units in HRTX?

After the reported transactions, Mark Earl Hensley held 343,750 Restricted Stock Units. Each RSU represents a contingent right to receive one share of Heron Therapeutics common stock upon vesting and settlement under the applicable award terms.

What is the vesting schedule for the reported HRTX Restricted Stock Units?

The Restricted Stock Units vest with 25% on the first anniversary of the grant date, May 6, 2025, and the remainder in twelve equal quarterly installments thereafter, as disclosed in the footnotes to the Form 4 filing.

What does the $0.5000 per share figure mean in the HRTX Form 4 filing?

The $0.5000 per share figure applies to 8,888 shares delivered or withheld in a transaction coded “F.” It represents the value used for payment of exercise price or tax liability related to the RSU exercise and resulting common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/10/2026 - 10:19 AM Accepted by SEC EDGAR 08/10/2026 - 10:18 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hensley Mark Earl

(Last) (First) (Middle)

25 FENTON MAIN STREET

SUITE 300

(Street)

CARY NORTH CAROLINA 27511

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HERON THERAPEUTICS, INC. /DE/ [ HRTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/06/2026		M		31,250	A	(1)	179,789	D
Common Stock	08/06/2026		F		8,888	D	$0.5	170,901	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	08/06/2026		M			31,250	(2)	(2)	Common Stock	31,250	$0	343,750	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of common stock.

2. The restricted stock units vest with 25% upon the first anniversary of date of grant (May 6, 2025) and then in twelve (12) equal quarterly installments thereafter.

	/s/Kathryn Lester Attorney-in-fact for Mark E. Hensley	08/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)